Showing results (81-90 of 196) with videos related to

Sort By:
Pageof 20
Transfusion Medicine Reviews|December 8, 2009
The use of immunoglobulin therapy for patients with primary immune deficiency: an evidence-based practice guidelineNadine Shehata, Valerie Palda, Tom Bowen, et al.
Frontiers in Immunology|May 10, 2021
Capturing T Lymphocytes' Dynamic Interactions With Human Neural Cells Using Time-Lapse MicroscopyFlorent Lemaître, Ana Carmena Moratalla, Negar Farzam-Kia, et al.
Aging Cell|March 25, 2010
Ionizing radiation-induced long-term expression of senescence markers in mice is independent of p53 and immune statusOanh N L Le, Francis Rodier, Francois Fontaine, et al.
Immunotherapy|January 11, 2019
Tolerability of subcutaneous immunoglobulin 20%, Ig20Gly, in pediatric patients with primary immunodeficienciesKenneth Paris, Elie Haddad, Michael Borte, et al.
Histopathology|March 8, 2012
CD133 expression is associated with poor outcome in neuroblastoma via chemoresistance mediated by the AKT pathwayHervé Sartelet, Tina Imbriglio, Carine Nyalendo, et al.
Frontiers in Immunology|September 7, 2023
KLRC1 knockout overcomes HLA-E-mediated inhibition and improves NK cell antitumor activity against solid tumorsAlice Mac Donald, Delphine Guipouy, William Lemieux, et al.
IJID Regions|March 19, 2026
Navigating Candidemia in a tertiary hospital: A 4-year epidemiologic and clinical reviewChadi Hage Chehade, Bassem Habr, Carine Harmouche, et al.
Genes, Chromosomes & Cancer|April 20, 2012
Genotype analysis of tumor-initiating cells expressing CD133 in neuroblastomaSonia Cournoyer, Carine Nyalendo, Anissa Addioui, et al.
Journal of the American Society of Nephrology : JASN|February 24, 2004
Glycosylation and size of IgA1 are essential for interaction with mesangial transferrin receptor in IgA nephropathyIvan C Moura, Michelle Arcos-Fajardo, Charlotte Sadaka, et al.
Pageof 20